Editorial on "Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension".
作者信息
Forbes Lindsay M
机构信息
Division of Pulmonary Sciences and Critical Care Medicine University of Colorado Anschutz Medical Center Aurora Colorado USA.
出版信息
Pulm Circ. 2024 Sep 20;14(3):e12444. doi: 10.1002/pul2.12444. eCollection 2024 Jul.
Abstract
摘要
相似文献
1
Editorial on "Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension".关于“联合化疗与免疫疗法治疗肺动脉高压”的社论
Pulm Circ. 2024 Sep 20;14(3):e12444. doi: 10.1002/pul2.12444. eCollection 2024 Jul.
2
Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension.联合化疗和免疫疗法的使用可改善肺动脉高压。
Pulm Circ. 2024 Sep 2;14(3):e12426. doi: 10.1002/pul2.12426. eCollection 2024 Jul.
3
Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma.晚期胃癌和食管胃交界腺癌的挽救性全身治疗
Cochrane Database Syst Rev. 2020 Nov 19;11(11):CD012078. doi: 10.1002/14651858.CD012078.pub2.
4
Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study.经肝动脉灌注化疗联合抗 PD-1/PD-L1 免疫治疗及分子靶向药物治疗晚期肝细胞癌的真实世界研究。
Front Immunol. 2023 Apr 26;14:1127349. doi: 10.3389/fimmu.2023.1127349. eCollection 2023.
5
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension.基于斑点追踪成像的全右心评估改善了肺动脉高压中经验证的评分系统的风险预测。
J Am Soc Echocardiogr. 2020 Nov;33(11):1334-1344.e2. doi: 10.1016/j.echo.2020.05.020. Epub 2020 Aug 1.
6
7
Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension.内皮素-1 受体 A 型免疫疗法治疗肺动脉高压。
J Am Coll Cardiol. 2019 May 28;73(20):2567-2580. doi: 10.1016/j.jacc.2019.02.067.
8
Investigational pharmacotherapy and immunotherapy of pulmonary arterial hypertension: An update.肺动脉高压的药物治疗和免疫治疗的研究进展：更新。
Biomed Pharmacother. 2020 Sep;129:110355. doi: 10.1016/j.biopha.2020.110355. Epub 2020 Jun 16.
9
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management.肺动脉高压的免疫治疗：从发病机制到临床管理。
Int J Mol Sci. 2024 Aug 1;25(15):8427. doi: 10.3390/ijms25158427.
10
Active and Passive Vaccination for Pulmonary Arterial Hypertension: A Novel Therapeutic Paradigm.
J Am Coll Cardiol. 2019 May 28;73(20):2581-2583. doi: 10.1016/j.jacc.2019.02.064.
本文引用的文献
1
Treatment algorithm for pulmonary arterial hypertension.肺动脉高压治疗算法。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01325-2024. Print 2024 Oct.
2
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.索他洛尔治疗肺动脉高压的3期试验
N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6.
3
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.分类学中的紧张局势：1 型和 3 型肺动脉高压的病理生物学基础和治疗的当前理解和未来方向。
Compr Physiol. 2023 Jan 30;13(1):4295-4319. doi: 10.1002/cphy.c220010.
4
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.肺动脉高压的病理学和病理生物学：现状和研究展望。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01887-2018. Print 2019 Jan.
Zotero 插件